logo

Breaking News

Share SHARE

Shares of Live Nation (LYV) have climbed off their worst levels of the day but continue to see notable weakness in late-day trading on Monday.

Shares of Cardinal Health (CAH) have moved significantly lower over the course of the trading session on Monday, slumping by 4.1 percent.

After showing an early move to the downside, shares of Shire (SHPG) continue to see considerable weakness in late-day trading on Monday.

Shares of General Motors (GM) have shown a notable upward move over the course of the trading day on Monday, climbing by 2.6 percent.

After gapping open sharply higher, shares of Cavium (CAVM) have pulled back off their best levels of the day but remain firmly positive in afternoon trading on Monday.

Shares of Intra-Cellular Therapies (ITCI) have shown a strong move to the upside during trading on Monday, surging up by 6 percent. With the advance, Intra-Cellular has reached its best intraday level in well over a month. The jump by Intra-Cellular comes after the FDA granted Fast Track designation...

Extending the pullback seen last Friday, shares of Wal-Mart (WMT) are seeing notable weakness in afternoon trading on Monday.

Worthington Industries, Inc. (WOR) announced that its Worthington Armstrong Venture, WAVE, has agreed to sell its business and operations in Europe, Middle East, Africa and Asia, to Knauf Group. Worthington expects to realize approximately $45 million for its 50% share of the WAVE operations being sold....

Zions Bancorporation (ZION) announced its intention to streamline corporate structure by merging the parent company into its banking subsidiary, ZB, N.A or one of its subsidiaries. The resulting entity will bear the name Zions Bancorporation, N.A. Zions will file an application with the Financial Stability...

Alnylam Pharmaceuticals, Inc. (ALNY), a RNAi therapeutics company, announced Monday that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation or BTD for patisiran, an investigational RNAi therapeutic targeting transthyretin. Patisiran is for the treatment of adults with...

Marvell Technology Group Ltd. (MRVL) and Cavium, Inc. (CAVM) announced a definitive agreement, under which Marvell will acquire all outstanding shares of Cavium common stock in exchange for consideration of $40.00 per share in cash and 2.1757 Marvell common shares for each Cavium share. This represents...

Dycom Industries, Inc. (DY), a provider of specialty contracting services, announced Monday that it expects second-quarter earnings per share to range from $0.15 to $0.27. Adjusted earnings per share is expected to range from $0.24 to $0.36. In the preceding first quarter, net income was $0.90 per...

Shares of DBV Technologies (DBVT) were gaining in Paris trading and Nasdaq pre-market on Monday after the company announced positive topline results from the Phase III REALISE trial of Viaskin Peanut for the treatment of Peanut-Allergic patients. The REAL Life Use and Safety of EPIT or REALISE trial...

LivaNova PLC (LIVN), a medical device company, announced Monday that it has entered into a binding Letter of Intent or LOI for the sale of Cardiac Rhythm Management or CRM Business Franchise to MicroPort Scientific Corp. for $190 million in cash. With the sale, LivaNova anticipates it will recognize...

Swiss drug major Novartis (NVS) announced Monday that the European Commission approved Tasigna (nilotinib) for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase or Ph+ CML-CP and pediatric patients with Ph+ CML-CP with...

Follow RTT